Gossamer Bio, Inc. Cash Flow Statement

Cash Flow Statement Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Operating Activities
Net Income -147.28M-182.51M-243.19M-234.80M-229.38M-179.82M-56.53M
Depreciation and Depletion 0.30M0.90M1.40M1.70M1.80M1.60M0.80M
Share-based Compensation 30.95M20.82M38.75M32.01M42.55M28.52M20.62M
Gains from Investment Securities 0.03M0.26M-0.02M3.03M-0.73M5.30M
Cash from Operations -51.04M-144.83M-176.36M-188.89M-187.03M-159.16M-3.47M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 2.36M2.86M3.43M2.60M9.45M13.06M
Amortization of Deferred Charges 0.24M3.86M6.73M1.16M1.32M1.09M
Depreciation & Amortization (CF) 0.30M0.92M1.41M1.74M1.83M1.61M0.83M
Change in Working Capital
Change in Receivables 5.34M
Change in Account Payables 2.08M-1.40M6.98M-4.43M-1.81M3.99M-1.66M
Change in Accured Expenses 10.53M8.61M-8.83M5.77M-1.66M-7.85M-10.72M
Other Working Capital Changes 2.83M4.39M2.85M3.58M2.72M3.89M55.92M
Investing Activities
Capital Expenditures 3.49M2.97M1.50M1.55M0.41M
Cash from Investing Activities -144.71M-147.14M215.34M-117.43M-1.03M-110.97M29.02M
Financing Activities
Other financing activities 2.14M
Cash from Financing Activities 300.86M321.58M312.54M3.33M117.09M190.15M-11.49M
Additional items
Exchange Rate Effect 0.07M0.01M-0.17M-0.52M0.11M-0.10M
Change in Cash 105.10M29.67M351.53M-303.15M-71.49M-79.86M13.96M
Beginning Cash Balance 0.04M
Free Cash Flow -54.53M-147.80M-177.86M-190.44M-187.44M-159.16M-3.47M
Net Cash Flow 105.10M29.60M351.52M-302.99M-70.98M-79.97M14.07M